reviewTop 1% cited
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
European Urology · 2013 · Vol. 64(1) · pp. 118–140
M. Oelke✉(Medizinische Hochschule Hannover)Alexander Bachmann(University Hospital of Basel)A. Descazeaud(Université de Limoges)Mark Emberton(University College London)Stavros Gravas(University of Thessaly)Martin C. Michel(Johannes Gutenberg University Mainz)James N’Dow(University of Aberdeen)Jørgen Nordling(Herlev Hospital)Jean J. de la Rosette(University of Amsterdam)
Urinary Bladder and Prostate ResearchProstate Cancer Diagnosis and TreatmentUrologic and reproductive health conditionsMedicineLower urinary tract symptomsUrinary systemUrologyProstateGynecologyInternal medicineCancer
MeSH terms
HumansMalePhosphodiesterase InhibitorsProstatic HyperplasiaSeverity of Illness IndexUrinary CatheterizationUrologyStentsTreatment OutcomeMuscarinic AntagonistsTransurethral Resection of ProstateRisk Reduction BehaviorWatchful WaitingAdrenergic alpha-1 Receptor Antagonists5-alpha Reductase Inhibitors
Citations
1,233
FWCI
159.34
field-weighted impact
References
193
Percentile
100%
vs. same field & year
Citations per year
Cited by
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction
European Urology · 2015 · 984 citations
References
Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
Urology · 1996 · 472 citations
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
The Journal of Urology · 2011 · 1,418 citations
Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial
Urology · 2003 · 383 citations
Morbidity, Mortality and Early Outcome of Transurethral Resection of the Prostate: A Prospective Multicenter Evaluation of 10,654 Patients
The Journal of Urology · 2008 · 748 citations
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
Urology · 2002 · 731 citations
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
European Urology · 2011 · 1,069 citations
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
European Urology · 2009 · 778 citations
2007 Guideline for the Management of Ureteral Calculi
European Urology · 2007 · 1,052 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
